Zhu M, Wu Y, Gao H, Qi F, Zhang X, Ran Y (2025) Differential regulation of mTOR activity in retinal ganglion cells underlies their distinct susceptibility to ischemia/reperfusion. Commun Biol 8(1):911. doi: 10.1038/s42003-025-08314-2 PMID: 40500296
Objective: To explore why intrinsically photosensitive retinal ganglion cells (ipRGCs) are more resistant to ischemia/reperfusion (I/R) injury than other RGC subtypes and to examine the role of mTOR signaling in this differential vulnerability.
Summary: ipRGCs exhibited higher mTOR activity and greater resistance to I/R injury compared to other RGCs. Rapamycin had cell-type–specific effects: it protected non-ipRGCs by increasing mTOR activity but suppressed mTOR in ipRGCs unless light was removed, revealing that light conditions critically influence mTOR-mediated neuroprotection.
Usage: Melanopsin (OPN4) was detected using Anti-Melanopsin (AB-N39) at a 1:2000 dilution to identify and quantify ipRGCs in retinal whole-mounts following ischemic injury.
Related Products: Melanopsin Rabbit Polyclonal, affinity-purified (Cat. #AB-N39)